Noggin produced in Sf9 Insect cells is a single, glycosylated polypeptide chain containing 211 amino acids (28-232a.a.) and having a molecular mass of 23.8kDa. (Molecular size on SDS-PAGE will appear at approximately 28-40kDa). Noggin is expressed with a 6 amino acid His tag at C-Terminus and purified by proprietary chromatographic techniques.
Noggin Human, Sf9
目录号: GP20785纯度: >98%
Noggin Human Recombinant, Sf9
| 规格 | 价格 | 库存 | 数量 | 操作 |
|---|---|---|---|---|
| 1μg | ¥840.00 | 现货 | 1 | |
| 5μg | ¥2,030.00 | 现货 | 1 | |
| 50μg | ¥16,800.00 | 现货 | 1 |
电话: 400-920-5774Email: sales@glpbio.cn
文献被引
本产品暂无引用记录;以下为 GlpBio 产品在 Nature / Cell / Science 等顶刊的客户引用样例
Nature641, 529–536 (2025)
Nature628, 630–638 (2024)
Nature632, 686–694 (2024)
Nature618, 1017–1023 (2023)
Nature610, 366–372 (2022)
Cell187(9):2288-2304 (2024)
Cell183(7):1867-1883 (2020)
Science388(6745) (2025)
Science387(6739) (2025)
Science387(6734) (2025)
Cell Research35, 97–116 (2025)
Cell Research34, 683–706 (2024)
Cell Research33, 273–287 (2023)
Cell Research33, 546–561 (2023)
Cell Research33, 904–922 (2023)
Cell Research31, 1291–1307 (2021)
产品描述 Description
产品文档 Product Documents
Purity:>98%
Product Data
Purity
Greaterthan 90.0% as determined by SDS-PAGE.
Source
Sf9,Insect cells.
Physical Appearance
Sterilefiltered colorless solution.
Shipping Condition
Shipped with Ice Packs.
Synonyms
Noggin;Symphalangism 1 (Proximal); Synostoses (Multiple) Syndrome 1; SYNS1A; SYNS1;SYM1.
Amino Acid Sequence
QHYLHIRPAPSDNLPLVDLI EHPDPIFDPK EKDLNETLLR SLLGGHYDPG FMATSPPEDR PGGGGGAAGG AEDLAELDQLLRQRPSGAMP SEIKGLEFSE GLAQGKKQRL SKKLRRKLQM WLWSQTFCPV LYAWNDLGSR FWPRYVKVGSCFSKRSCSVP EGMVCKPSKS VHLTVLRWRC QRRGGQRCGW IPIQYPIISE CKCSCHHHHH H.
Stability
Store at 4°C if entire vial will be used within 2-4 weeks.Store, frozen at -20°C for longer periods of time. For long term storage it is recommended to add a carrier protein (0.1% HSA or BSA).Avoid multiple freeze-thaw cycles.
Formulation
Noggin a protein solution (0.25mg/ml) contains phosphate buffered saline (pH7.4) and 10% glycerol.
